US Patent 7105540 Cholinesterase inhibitors to treat disorders of attention
Patent 7105540 was granted and assigned to Eisai (company) on September, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+195 characters)
Article
Patent abstract
The present invention provides novel methods of treating disorders of attention or improving attention in humans by administering an effective amount of a cholinesterase inhibitor.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07105540 Cholinesterase inhibitors to treat disorders of attention US Patent 7105540 Cholinesterase inhibitors to treat disorders of attention
Infobox
Patent Number
0710554000
Patent Number
710554000
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071055400
Date of Patent
September 12, 2006
0Patent Application Number
102537310
Date Filed
September 24, 2002
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071055400
Date of Patent
September 12, 2006
0Patent Application Number
102537310
Date Filed
September 24, 2002
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07105540 Cholinesterase inhibitors to treat disorders of attention
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07105540
Date of patent
September 12, 2006
Patent application number
10253731
Date Filed
September 24, 2002
Patent primary examiner
Find more entities like US Patent 7105540 Cholinesterase inhibitors to treat disorders of attention
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
